Generic Ibrance (palbociclib) Price

Palbociclib price by strength

Palbociclib names

- Brand name: Ibrance (Pfizer)
- Generic name: palbociclib
- Names in Canada: Ibrance, plus generics such as Pms-Palbociclib and Taro-Palbociclib (Health Canada Drug Product Database, marketed products, checked Oct 29, 2026)

Palbociclib packs made for other countries are not FDA-approved.

Palbociclib FAQ

Brand vs. generic: cost for 90 days

Lowest in this comparison: Brand Ibrance, U.S. list price.

90 days = 67.5 tablets of 125 mg tablet. Generic sold abroad is not FDA-approved and is not in this box. Your price with insurance or Medicare depends on your plan.

See brand Ibrance prices

Palbociclib cost with Medicare in 2026

Each Part D plan has its own list of covered drugs and copays (Medicare Plan Finder). No FDA-approved generic palbociclib is sold in the U.S. yet. Check how your plan covers brand Ibrance; the Ibrance page has Medicare details. In 2026, Part D plans can have a yearly deductible of up to $615, and your out-of-pocket costs for covered drugs are capped at $2,100 a year ($2,400 in 2027) (Medicare.gov).

Savings programs from the maker

eDrugSearch does not offer its own Palbociclib coupons. Maker savings and assistance programs are for brand Ibrance only, not generic palbociclib from abroad (see the Ibrance page). eDrugSearch has no coupons of its own. These programs can lower prescription costs if you have Medicare:

• Medicare Extra Help: if you have Medicare and limited income, Extra Help lowers what you pay for prescriptions. (Social Security)
• Medicare Prescription Payment Plan: a free Medicare option that spreads your drug costs into monthly payments across the year. It doesn't lower the total, but it can make costs easier to manage. (Medicare.gov)

When people choose brand Ibrance

Some people get brand Ibrance instead of generic palbociclib. Common reasons:

• In the U.S., palbociclib is sold only as brand Ibrance. The Ibrance page shows U.S. prices, prices abroad and the maker's savings programs.
• Some insurance and Medicare drug plans cover brand Ibrance. Your plan's drug list shows whether it does and what you pay.

Your prescriber decides which medicine is right for you.

Compare prices for your other medicines

• Ibrance prices from $1,059.59 for 90 days

Lowest 90-day price including shipping, from licensed pharmacies shipping to the U.S., any strength.

What is Palbociclib used for?

Palbociclib is the active ingredient in Ibrance. Ibrance (palbociclib) is a kinase inhibitor (a CDK 4/6 inhibitor). According to its FDA label (DailyMed), it is used in adults:

• For hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer, together with an aromatase inhibitor as the first hormone-based treatment, or together with fulvestrant after the cancer has grown on hormone therapy.
• Together with inavolisib and fulvestrant for HR-positive, HER2-negative, PIK3CA-mutated locally advanced or metastatic breast cancer that came back during or after hormone therapy given after surgery, as found by an FDA-authorized test.
• Together with trastuzumab (with or without pertuzumab) and hormone therapy as maintenance treatment for HR-positive, HER2-positive locally advanced or metastatic breast cancer after first (induction) treatment.

Ibrance comes as 75, 100 and 125 mg tablets (boxes of 3 weekly blister packs of 7) and capsules (bottles of 21). The label's schedule is one dose a day for 21 days, then 7 days off, in 28-day cycles. The capsules are taken with food; the tablets can be taken with or without food. Ibrance has no boxed warning; the label warns about low white blood cell counts (neutropenia), lung inflammation (ILD/pneumonitis) and harm to an unborn baby. Your prescriber decides which medicine is right for you.